Faricimab, CAS 1607793-29-2

Product Description: Faricimab is a bispecific antibody targeting angiopoietin-2 and vascular endothelial growth factor-A (VEGF-A). Faricimab can be used for diabetic macular edema (DME) research[1].

Applications: Metabolism-protein/nucleotide metabolism

Formula: N/A

References: [1]Sahni J, et al. Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial. Ophthalmology. 2019 Aug;126(8):1155-1170.

CAS Number: 1607793-29-2

Molecular Weight: N/A

Compound Purity: 97.97

Research Area: Metabolic Disease

Solubility: H2O

Target: VEGFR

• Artikelnummer: MEXHY-P99116-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99116-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK